Multiple tracer methods have been introduced to measure systemic glucose turnover in vivo. These methods share the same physiologic principles, but differ in technical details such as the site of isotope labeling, the use of stable or radioactive isotopes, and detection techniques. Stable isotopes are now preferred for practical and ethical reasons despite lower sensitivity compared to radiotracers. If glucose turnover is the sole purpose of an experiment, mass spectrometry is usually chosen because of high sensitivity, simplicity of data interpretation, and wide application (1, 2) . However, if multiple stable isotopes or labeling patterns are used in a single study to probe additional metabolic pathways, then NMR offers the benefit that multiple sites of 13 C or 2 H labeling in a glucose molecule are easily distinguished. This property offers an overwhelming advantage compared to mass spectrometry. There is increasing interest in simultaneous measurement of both glucose turnover and other metabolic fluxes in vivo. For example, administration of 2 H 2 O followed by measurement of deuterium enrichment in positions 2, 5, and 6 of glucose by mass spectrometry allowed Saadatian et al. to calculate the relative rates of glucose production (GP) from glycerol, glycogen, and the TCA cycle (3) . After co-administration of 2 H 2 O (oral) plus [6,6-2 H 2 ]glucose by continuous i.v. infusion, plasma glucose becomes enriched in multiple sites. The ratio of enrichment in position 5 compared to position 2 (or plasma water) yielded the fraction of plasma glucose derived from gluconeogenesis; whole-body turnover of glucose was measured from the 2 
Protocol
This study was approved by the Institutional Animal Care and Use Committee at UT Southwestern Medical Center. Male Sprague-Dawley rats weighing 201 Ϯ 12 g were fasted for 24 h with free access to water, after which the jugular vein was cannulated under ketamine/xylazine anesthesia. Rats received primed infusions of [3,4-13 C 2 ]glucose (n ϭ 6), [6,6- 2 H 2 ]glucose (n ϭ 6), or a mixture of both tracers (n ϭ 6). In each case, 35 mol/kg bolus of each tracer was given and followed by continuous infusion at the rate of 1 mol/kg/min for 90 min. Thus, the glucose amount in both prime and infusion was doubled in rats that received both tracers compared to rats that received a single tracer. At the end of each infusion protocol, ϳ6 mL of blood was drawn from the descending aorta under general anesthesia and the animal was sacrificed.
Sample Processing
Plasma glucose was assayed enzymatically (5). Whole blood was immediately deproteinized by treatment with cold perchloric acid to the final concentration of 7% by volume. After neutralization with KOH and centrifugation, the supernatant was lyophilized. Dried glucose was converted into MAG (6) . MAG samples (varying in 2 H enrichment from 0.49 to 9.83%, constant 22 mol in each sample) for generation of standard curves were prepared by mixing known amounts of natural abundance glucose and [6,6-2 H 2 ]glucose prior to chemical conversion to MAG. For 1 H and 2 H NMR acquisition, MAG was dissolved either in a mixture of 170 L acetonitrile, 4 L water, and 2 L DMF-d 7 (1.2%) or in a mixture of 164 L acetonitrile, 6 L water, and 10 L deuterated formate (4.2%). After 1 H and 2 H NMR acquisition, MAG was lyophilized and resuspended in 180 L deuterated acetonitrile (99.8%) for 13 C NMR acquisition.
NMR Spectroscopy
All NMR spectra were collected using a Varian Inova 14.1-T spectrometer (Varian Instruments, Palo Alto, CA, USA) equipped with a 3-mm broadband probe with the observe coil tuned to 1 H (600 MHz), 2 H (92 MHz), or 13 C (150 MHz). After shimming performed on selected 1 H resonances of MAG, 1 H NMR spectra were acquired using a 90°pulse (11 s), 8000 Hz sweep width, 47,998 data points, a 3-s acquisition time, and a 1-s interpulse delay at 50°C.
1 H NMR spectra were averaged over 16 scans requiring ϳ2 min. The acetonitrile signal was presaturated using a frequency-selective pulse in acquiring 1 H NMR. Protondecoupled 2 H NMR spectra were acquired using a 90°p ulse (12.5 s), 920 Hz sweep width, 1836 number of data points, and a 1-s acquisition time with no further delay at 50°C. Typically 6400 -20000 scans were averaged, requiring ϳ2-5 h. Proton decoupling was performed using a standard WALTZ-16 pulse sequence. 13 C NMR spectra were collected using 52°pulse (6.06 s), 20330 Hz sweep, with 60992 data points, and a 1.5-s acquisition time with no further delay at 25°C (4). Typically 4000 -40000 scans were averaged, requiring ϳ2-18 h. NMR spectra were analyzed using the curve-fitting routine supplied with the NUTS PC-based NMR spectral analysis program (Acorn NMR, Inc., Freemont, CA, USA).
Measurement of Glucose Production
Glucose turnover was measured by dilution of infused [3,4- Fig. 1 . One of the methyl resonances of DMF (2.8 ppm) was chosen for use as an internal reference to standardize the measurement of glucose H6 multiplet areas in the 1 H (A H6(RϩS) ) and 2 H NMR (A D6(RϩS) ) resonances. The DMF methyl resonance at 2.8 ppm was set arbitrarily to 100 in each spectrum. A standard curve was generated using seven samples by plotting actual enrichment of [6,6-2 H 2 ]glucose versus the ratio, (A D6(RϩS) )/(A H6(RϩS) ) (Fig. 2) . The linear correlation shown in Fig. 2 is described by L ϭ 0.72x ϩ 0.2692, where L is the % [6,6-2 H 2 ]glucose in each sample and x is the area ratio, A D6(RϩS) /A H6(RϩS) (r 2 ϭ 0.996). In measuring the excess enrichments of both tracers, standard curves were generated by running known standard samples using the NMR conditions described above. Under these NMR conditions, many signals were not fully relaxed. For example, a 1-s interpulse delay after 90°pulse width in 1 H NMR is insufficient for full relaxation. However, data from the standards were collected under identical conditions, so the standard curves remain valid.
GP was calculated from the known infusion rate (R i ), the fraction of infusate glucose that was [6, 
Statistical Analysis
The data are expressed as means Ϯ SD. Comparisons between groups were performed using one-way analysis of variance. Differences in mean values were considered statistically significant at the probability level of less than 5% (P Ͻ 0.05).
RESULTS
The three resonances of DMF-d 7 (2.6, 2.8, and 7.95 ppm) are well resolved from all MAG resonances in the 1 H and 2 H NMR spectra (Fig. 1, upper panels) . The methyl resonance at 2.8 ppm was used as a reference because the one at 2.6 ppm was closer to a broad water resonance at ϳ2.3 ppm, especially in the 1 H NMR spectrum (not shown). There was an excellent linear correlation (Fig. 2) between excess enrichment of [6,6-2 H 2 ]glucose versus the ratio, (A D6(RϩS) )/(A H6(RϩS) ). The doublets of [3,4-13 C 2 ]glucose and methyl groups of MAG were also well resolved in the 13 C NMR spectrum (Fig. 1, bottom To test whether the trend toward difference in GP as reported by the two tracers might be due to error propagation from (a) two different groups of animals and(b) two different NMR nuclei and samples, GP was measured again in a single group of rats after administration of both tracers simultaneously. This approach takes advantage of the fact that NMR detection of [ Plasma [3, 4 
DISCUSSION
The values of GP determined here were all within the range of values, typically 32 to 67 mol/kg/min, reported for fasted rats using various techniques (3,8,9 -11 2 H]Glucose is thought to overestimate glucose turnover because the deuterium can be lost by exchange between glucose-6-phosphate and fructose-6-phosphate which results in appearance of unlabeled plasma glucose. In fact, glucose turnover measured by [2- 2 H]glucose (or the radioactive counterpart) has been compared to other measures of glucose turnover to specifically assess futile cycling between extracellular glucose and the glucose-6-phosphate pool (12, 13) . In contrast, the deuterium labels of [6,6-2 H 2 ]glucose are not lost during futile cycling, and for this reason [6,6-2 H 2 ]glucose is considered to report the true value of hepatic GP (14, 15) .
This study introduces a new method for the quantification of deuterium enrichment of plasma glucose. Sodium formate was proposed earlier as an internal reference for the quantification (7), but DMF-d 7 has significant advantages over formate. The methyl resonances of DMF-d 7 are reasonably sharp while the 1 H NMR signal of formate is rather broad, and this could contribute to errors in measurement of resonance areas. Of the two DMF methyl resonances (2.6 ppm and 2.8 ppm), the peak at 2.8 ppm was chosen in this work because a broad water peak often appears near 2.6 ppm in samples that require addition of more water than used here to increase the solubility of MAG (MAG has a limited solubility in neat acetonitrile). Another advantage is that DMF-d 7 can be easily removed from MAG by drying, which is an advantage if later processing of the sample is required.
[3,4-13 C 2 ]Glucose offers two critical advantages compared to other 13 C tracers of glucose. A basic assumption in measurement of glucose turnover is that a tracer molecule is not released from liver as the result of glycogenolysis or gluconeogenesis. A number of biochemical pathways could be followed by [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose and it is important to consider whether [3,4- 13 C 2 ]glucose (or other labeling patterns) could be generated. Oxidation of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose to pyruvate followed by decarboxylation to acetyl-CoA would yield only 13 CO 2 . Metabolism in the pentose phosphate pathway could yield complex labeling patterns in the triose pool, but only natural abundance singlets have been observed in positions 1, 2, 5, or 6, suggesting that this pathway does not impact the labeling patterns in plasma glucose. Metabolism of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose to the level of the triose pool followed by resynthesis could in principle regenerate [3,4- 13 C 2 ]glucose (Fig. 3) . However, [3,4- 13 C 2 ]glucose represents at most about 2% of the glucose pool, so the chance that a molecule of [3,4- 13 C 2 ]glucose was derived by degradation and resynthesis is Յ 0.04%. [3,4- 13 C 2 ]Glucose offers another, less obvious advantage: metabolism to pyruvate followed by carboxylation, further metabolism in the TCA cycle, and resynthesis to glucose cannot yield glucose labeled in any site other than positions 3 or 4 (Fig. 3) . This is a significant advantage compared to alternative 13 C-tracers such as [1,6- 13 C 2 ]glucose or [U- 13 C 6 ]glucose, whose metabolism through pyruvate carboxylase could yield label throughout glucose produced by gluconeogenesis. This feature can be exploited because another 13 C-enriched gluconeogenic substrates that yield 13 C in positions 1, 2, 5, or 6 of glucose can be monitored simultaneously (4) . The main disadvantage of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose is its high price because it is a novel tracer.
In summary, glucose turnover measured by NMR detection of [3,4- 13 C 2 ]glucose was equivalent to results using a standard tracer of glucose turnover, [6,6-2 H 2 ]glucose. One significant advantage of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose is that carefully selected other 13 C tracers of TCA cycle metabolism can be used in the same experiment to probe multiple metabolic pathways (4). Furthermore, since NMR detection of either 13 C or 2 H is not sensitive to the presence of the other nucleus at the levels of enrichment typically used in these experiments, further metabolic information can also be obtained from a 2 H NMR spectrum of the same sample (4). Combining these tracers allows a relatively complete analysis of hepatic fluxes from a single blood sample, including GP, glycogenolysis, gluconeogenesis from glycerol, gluconeogenesis from phosphoenol pyruvate, 
